TNF and inflammatory bowel disease: The IBD pharmacological treatments are based on anti-inflammatory drugs (e.g., mesalazine), biologics acting as cytokine blockers (anti-TNF-α antibodies such as Adalinumab and Infliximab), steroids or immunosuppressants such as azathioprine and methotrexate [6].